Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Venkatesan Radha

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
Diabetes Technology & Therapeutics|June 12, 2020
Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from LockdownRanjit Mohan Anjana, Rajendra Pradeepa, Mohan Deepa, et al.
Diabetes Care|January 19, 2022
Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort StudyIfy R Mordi, Emanuele Trucco, Mohammad Ghouse Syed, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Selection-guided discovery in South Asians implicates the MAPT locus in insulin resistanceErwan Pennarun, Borbala Banfalvi, Yuemin Li, et al.
Journal of Affective Disorders|April 26, 2025
Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptomsChinnasamy Thirumoorthy, Kuldeep Kumar Sharma, Mohan Deepa, et al.
Hypertension (Dallas, Tex. : 1979)|June 22, 2016
Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide PathwayMalapaka Kiranmayi, Venkat R Chirasani, Prasanna K R Allu, et al.
Cell Genomics|July 26, 2023
Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteinsNatalie DeForest, Babu Kavitha, Siqi Hu, et al.
Scientific Reports|June 1, 2016
An Improved Method for High Quality Metagenomics DNA Extraction from Human and Environmental SamplesSatyabrata Bag, Bipasa Saha, Ojasvi Mehta, et al.
Diabetes|December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
BMC Medical Genetics|February 15, 2018
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South IndiaViswanathan Mohan, Venkatesan Radha, Thong T Nguyen, et al.
Genome Medicine|March 4, 2021
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and IndiaCamila Alvarez-Silva, Alireza Kashani, Tue Haldor Hansen, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|June 12, 2020
Acceptability and Utilization of Newer Technologies and Effects on Glycemic Control in Type 2 Diabetes: Lessons Learned from LockdownRanjit Mohan Anjana, Rajendra Pradeepa, Mohan Deepa, et al.
Diabetes Care|January 19, 2022
Prediction of Major Adverse Cardiovascular Events From Retinal, Clinical, and Genomic Data in Individuals With Type 2 Diabetes: A Population Cohort StudyIfy R Mordi, Emanuele Trucco, Mohammad Ghouse Syed, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Selection-guided discovery in South Asians implicates the MAPT locus in insulin resistanceErwan Pennarun, Borbala Banfalvi, Yuemin Li, et al.
Journal of Affective Disorders|April 26, 2025
Epigenome-wide association study identifies a specific panel of DNA methylation signatures for antenatal and postpartum depressive symptomsChinnasamy Thirumoorthy, Kuldeep Kumar Sharma, Mohan Deepa, et al.
Hypertension (Dallas, Tex. : 1979)|June 22, 2016
Catestatin Gly364Ser Variant Alters Systemic Blood Pressure and the Risk for Hypertension in Human Populations via Endothelial Nitric Oxide PathwayMalapaka Kiranmayi, Venkat R Chirasani, Prasanna K R Allu, et al.
Cell Genomics|July 26, 2023
Human gain-of-function variants in HNF1A confer protection from diabetes but independently increase hepatic secretion of atherogenic lipoproteinsNatalie DeForest, Babu Kavitha, Siqi Hu, et al.
Scientific Reports|June 1, 2016
An Improved Method for High Quality Metagenomics DNA Extraction from Human and Environmental SamplesSatyabrata Bag, Bipasa Saha, Ojasvi Mehta, et al.
Diabetes|December 4, 2021
Functional Gly297Ser Variant of the Physiological Dysglycemic Peptide Pancreastatin Is a Novel Risk Factor for Cardiometabolic DisordersPrasanna K R Allu, Malapaka Kiranmayi, Sromona D Mukherjee, et al.
BMC Medical Genetics|February 15, 2018
Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South IndiaViswanathan Mohan, Venkatesan Radha, Thong T Nguyen, et al.
Genome Medicine|March 4, 2021
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and IndiaCamila Alvarez-Silva, Alireza Kashani, Tue Haldor Hansen, et al.
Pageof 9